Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-01-01 @ 7:36 AM
Study NCT ID:
NCT05239832
Status:
UNKNOWN
Last Update Posted:
2022-03-03
First Post:
2022-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Sponsor:
Livzon Pharmaceutical Group Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-10
First Submit QC Date:
None
Study First Post Date:
2022-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-15
Last Update Post Date:
2022-03-03
Last Update Post Date Type:
ACTUAL